Waks et al. categorized breast cancer into three major subtypes based on the presence or absence of molecular markers, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast cancer.